Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Proteinase K Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing demand for nucleic acid purification
5.1.1.2. Improved cloning efficiency and tissue digestion
5.1.1.3. Demand for proteinase K in POC diagnostics applications
5.1.2. Restraints
5.1.2.1. Presence of substitute
5.1.3. Opportunities
5.1.3.1. Growing R&D in the field like 3D printing and tissue reengineering
5.1.3.2. Government initiatives taken in pharmaceutical industry
5.1.4. Challenges
5.1.4.1. Introduction of new sophisticated technologies for DNA purification
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Proteinase K Market, by Therapeutic Area
6.1. Introduction
6.2. Autoimmune Diseases
6.3. Cardiology
6.4. Diabetes
6.5. Infectious Diseases
6.6. Nephrology
6.7. Neurology
6.8. Oncology

7. Proteinase K Market, by Form
7.1. Introduction
7.2. Liquid
7.3. Powder

8. Americas Proteinase K Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Proteinase K Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Proteinase K Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Advanced Enzymes Technologies Ltd.
12.1.2. Amano Enzyme Inc.
12.1.3. American Laboratories
12.1.4. Biocatalysts Ltd.
12.1.5. BIORON GmbH
12.1.6. Codexis, Inc.
12.1.7. Dyadic International, Inc.
12.1.8. F. Hoffmann-La Roche Ltd.
12.1.9. Gproan Biotechnologies
12.1.10. Merck KGaA
12.1.11. Norgen Biotek Corporation
12.1.12. Promega Corporation
12.1.13. Qiagen N.V.
12.1.14. Thermo Fisher Scientific, Inc.
12.1.15. Worthington Biochemical Corporation
12.2. Key Product Portfolio

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing



List of Figures

FIGURE 1. PROTEINASE K MARKET RESEARCH PROCESS
FIGURE 2. PROTEINASE K MARKET SIZE, 2023 VS 2030
FIGURE 3. PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PROTEINASE K MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PROTEINASE K MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PROTEINASE K MARKET DYNAMICS
FIGURE 7. PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
FIGURE 8. PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PROTEINASE K MARKET SIZE, BY FORM, 2023 VS 2030 (%)
FIGURE 10. PROTEINASE K MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS PROTEINASE K MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS PROTEINASE K MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES PROTEINASE K MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES PROTEINASE K MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC PROTEINASE K MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC PROTEINASE K MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PROTEINASE K MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PROTEINASE K MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. PROTEINASE K MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. PROTEINASE K MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. PROTEINASE K MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PROTEINASE K MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 6. PROTEINASE K MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PROTEINASE K MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. PROTEINASE K MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. PROTEINASE K MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. PROTEINASE K MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. PROTEINASE K MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. PROTEINASE K MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 14. PROTEINASE K MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. PROTEINASE K MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS PROTEINASE K MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 19. ARGENTINA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 20. ARGENTINA PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 21. BRAZIL PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 22. BRAZIL PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 23. CANADA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 24. CANADA PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 25. MEXICO PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 26. MEXICO PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES PROTEINASE K MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 30. ASIA-PACIFIC PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 31. ASIA-PACIFIC PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 32. ASIA-PACIFIC PROTEINASE K MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. AUSTRALIA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 34. AUSTRALIA PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 35. CHINA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 36. CHINA PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 37. INDIA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 38. INDIA PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 39. INDONESIA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 40. INDONESIA PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 41. JAPAN PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 42. JAPAN PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 43. MALAYSIA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 44. MALAYSIA PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 45. PHILIPPINES PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 46. PHILIPPINES PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 47. SINGAPORE PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 48. SINGAPORE PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 49. SOUTH KOREA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 50. SOUTH KOREA PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 51. TAIWAN PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 52. TAIWAN PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 53. THAILAND PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 54. THAILAND PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 55. VIETNAM PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 56. VIETNAM PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA PROTEINASE K MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 60. DENMARK PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 61. DENMARK PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 62. EGYPT PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 63. EGYPT PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 64. FINLAND PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 65. FINLAND PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 66. FRANCE PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 67. FRANCE PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 68. GERMANY PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 69. GERMANY PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 70. ISRAEL PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 71. ISRAEL PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 72. ITALY PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 73. ITALY PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 74. NETHERLANDS PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 75. NETHERLANDS PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 76. NIGERIA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 77. NIGERIA PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 78. NORWAY PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 79. NORWAY PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 80. POLAND PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 81. POLAND PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 82. QATAR PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 83. QATAR PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 84. RUSSIA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 85. RUSSIA PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 86. SAUDI ARABIA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 87. SAUDI ARABIA PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 88. SOUTH AFRICA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 89. SOUTH AFRICA PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 90. SPAIN PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 91. SPAIN PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 92. SWEDEN PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 93. SWEDEN PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 94. SWITZERLAND PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 95. SWITZERLAND PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 96. TURKEY PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 97. TURKEY PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 98. UNITED ARAB EMIRATES PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 99. UNITED ARAB EMIRATES PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 102. PROTEINASE K MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 103. PROTEINASE K MARKET SHARE, BY KEY PLAYER, 2023
TABLE 104. PROTEINASE K MARKET LICENSE & PRICING